PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Reveals whether the business's core operations generate sufficient cash to cover expenses, fund growth, and return capital to shareholders. Sustainable free cash flow is often a key indicator of long-term value creation.
0.08
OCF/share of 0.08 while Healthcare median is zero. Walter Schloss would see if modest cash generation can build a stronger lead.
0.08
FCF/share of 0.08 while Healthcare median is zero. Walter Schloss would see if small leftover cash can become a big advantage.
No Data
No Data available this quarter, please select a different quarter.
1.12
Ratio 1.25–1.5x Healthcare median of 0.88. Mohnish Pabrai would confirm that earnings truly convert to cash better than peers.
No Data
No Data available this quarter, please select a different quarter.